Publications

Export 63 results:
Sort by: [ Author (Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Sabrya, D., A. Shamaa, M. Amer, O. El-Tookhy, A. Abdallahc, D. M. A. E. Hassibd, E. Amer, and A. E. Amir, "The Effect of Mesenchymal Stem Cell Derived Microvesicles in Repair of Femoral Chondral Defects in Dogs", Journal of Musculoskeletal Research , vol. Mar 08, 2018.
Salem, N., M. Y. Salem, M. M. Elmaghrabi, M. A. Elawady, M. A. Elawady, D. Sabry, A. Shamaa, A. - H. H. Elkasapy, N. Ibrhim, and A. E. Amir, "Does vitamin C have the ability to augment the therapeutic effect of bone marrow-derived mesenchymal stem cells on spinal cord injury?", Neural Regeneration Research , vol. 12 (12), pp. 2050-2058, 2017.
Salem, N., E. Ehsan, E. A. Ghany, D. Sabry, and A. Shamaa, "Mesenchymal stem cells transplantation attenuates brain injury in experimentally induced neonatal hypoxia", Tissue and Cell, 2018.
Samer, M., E. A. Imam, A. A. Shamaa, and A. A. Mostafa, "Establishment of Amniotic Membrane Bank for Orthopaedic Surgery in dogs: Clinical and Radiographic Assessment. ", Journal of the egyptian veterinary medical association Vol 74(4)519-531, 2014.
Samer, M., F. A. Torad, A. A. Shamaa, O. S. El-Tookhy, D. S. A. Fatah, L. A. Rashed, M. A. Hamid, S. M. Mahfouz, and D. M. Gharib, "Role of Endothelial Progenitor Cells in Management of Myocardial Infarction Following Total Coronary Occlusion in Dogs.", Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 7, issue 3, pp. 1225-1237, 2016. endothelial_progenitor_cells.pdf
Saravanan, S., N. Sareen1, E. Abu-El-Rub, H. Ashour, G. L. Sequiera, H. I. Ammar, V. Gopinath, A. A. Shamaa, S. S. E. Sayed, M. Moudgil, et al., "Graphene Oxide-Gold Nanosheets Containing Chitosan Scaffold Improves entricular Contractility and Function After Implantation into Infarcted Heart", SCIENTIFIC RepOrtS , vol. 8, pp. 15069, 2018.
Shamaa, A., A. N. Abdallah, M. Bahr, and O. E. S. Tookhy, "A review: Multiple Sclerosis Treatment: Current Strategies and Future Hopes", Alexandria Journal of Veterinary Sciences, 2020.
Shamaa, A., D. E. Hanafy2, T. F. Khalifa, M. M. Salem, G. G. Shehab, N. M. Aly, and E. HASSAN, "Pressure-induced left ventricular hypertrophy in canine model of aortic stenosis using nylon tie", Acta Scientiarum. Biological Sciences, vol. 42, 2020.
Shoukry, H. S., H. I. Ammar, L. A. Rashed, M. B. Zikri, A. A. Shamaa, S. G. Abou Elfadl, E. A. - A. Rub, S. Saravanan, and S. Dhingra, "Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity.", PloS one, vol. 12, issue 7, pp. e0181535, 2017. Abstract

Resveratrol (RSV), a polyphenolic compound and naturally occurring phytoalexin, has been reported to exert cardio-protective effects in several animal studies. However, the outcome of initial clinical trials with RSV was less effective compared to pre-clinical studies. Therefore, RSV treatment protocols need to be optimized. In this study we evaluated prophylactic versus therapeutic effect of resveratrol (RSV) in mitigating doxorubicin (Dox)-induced cardiac toxicity in rats. To investigate prophylactic effects, RSV was supplemented for 2 weeks along with Dox administration. After 2 weeks, Dox treatment was stopped and RSV was continued for another 4 weeks. To study therapeutic effects, RSV treatment was initiated after 2 weeks of Dox administration and continued for 4 weeks. Both prophylactic and therapeutic use of RSV mitigated Dox induced deterioration of cardiac function as assessed by echocardiography. Also RSV treatment (prophylactic and therapeutic) prevented Dox induced myocardial damage as measured by cardiac enzymes (LDH and CK-MB) in serum. Which was associated with decrease in Dox induced myocardial apoptosis and fibrosis. Interestingly our study also reveals that prophylactic use of RSV was more effective than its therapeutic use in mitigating Dox induced apoptosis and fibrosis in the myocardium. Therefore, prophylactic use of resveratrol may be projected as a possible future adjuvant therapy to minimize cardiotoxic side effects of doxorubicin in cancer patients.

Soliman, A. S., M. S. Amer, A. A. Shamaa, G. G. S. Dina Sabry, and O. H. Ayman Magdy Mostafa, "Study the efficacy of chitosan as a scaffold for management of experimentally induced femoral bone defect in dogs. ", Journal of the egyptian veterinary medical association Vol 75(1) 111-123., 2015.
Soliman, A. S., M. S. Amer, A. A. Shamaa, D. Sabry, G. G. Shehab, and O. Hagag, "Using of Chitosan seeded with autologous undifferentiated Mesenchymal Stem Cells for Femoral Bone Defect Management in dog", Dogs. Research Journal of Pharmaceutical, Biological and Chemical Sciences (RJPBCS);, issue 6(4):1220-1231., 2015.
Soliman, A. S., M. S. Amer, A. A. Shamaa, and G. G. S. Dina Sabry, "Study the efficacy of chitosan as a scaffold for management of experimentally induced femoral bone defect in dogs. ", Journal of the egyptian veterinary medical association Vol 75(1) 111-123, 2015.
W
Walla’a A. Osman, I. Z. M. Y. W. M. Salwa A. Elmessiry, Olfat Shaker, A. M. S, and S. A.A, "Comparative study of the effect of Diacerein and Diclofenac sodium and their combination in osteoarthritis model induced by monoiodoacetate in albino rats. ", Research Journal of Pharmaceutical, Biological and Chemical Sciences (RJPBCS) 6(3) 1079-1089, 2015.
Tourism